Adenylosuccinic acid tetraammonium

腺苷酸琥珀酸四铵

Adenylosuccinic acid tetraammonium

A659402-10mg

10mg

≥98%

-20°C储存,干燥

超低温冰袋运输

Adenylosuccinic acid tetraammonium (Adenylosuccinate; Aspartyl adenylate) is an orally active purine ribonucleoside monophosphate and plays a role in nucleotide cycle metabolite . Adenylosuccinic acid tetraammonium can be converted into fumaric acid throu Appearance:Solid IC50& Target:Human Endogenous Metabolite In Vivo:Adenylosuccinic acid tetraammonium (oral administration; 3-3000 µg/mL; 6 weeks) significantly improves the features of murine DMD, it decreases the number of centronucleated fibres, lipid accumulation, connective tissue infiltration and Ca 2+ content of m Biological Activity:Adenylosuccinic acid tetraammonium (Adenylosuccinate; Aspartyl adenylate) is an orally active purine ribonucleoside monophosphate and plays a role in nucleotide cycle metabolite . Adenylosuccinic acid tetraammonium can be converted into fumaric acid throu

C14H30N9O11P

531.42 g/mol

O=C(C[C@H](NC1=C2N=CN(C2=NC=N1)[C@H]3[C@H](O)[C@H](O)[C@H](O3)COP(O)(O)=O)C(O)=O)O.N.N.N.N

H2O : 200 mg/mL (376.35 mM; Need ultrasonic)